Ranitidine hydrochloride, commonly known as Zantac, was a popular medication for reducing stomach acid. Its manufacturing involved multiple companies globally.
Who made Ranitidine hydrochloride?
Numerous pharmaceutical companies manufactured ranitidine hydrochloride. The active ingredient was produced by various chemical manufacturers, and then formulated into tablets, capsules, and liquid solutions by drug companies. Some of the prominent manufacturers included:
* Sanofi: As the originator of Zantac, Sanofi was a primary manufacturer [1].
* Generic Manufacturers: Following patent expirations, a wide array of generic drug companies produced ranitidine hydrochloride. These included companies like Teva Pharmaceuticals, Mylan, and Novitium Pharma, among many others [2][3].
Why was Ranitidine hydrochloride recalled?
Ranitidine hydrochloride was voluntarily recalled by many manufacturers and withdrawn from markets in several countries, including the United States and Canada, starting in late 2019 and continuing into 2020. This action was prompted by concerns over the presence of N-Nitrosodimethylamine (NDMA), a probable human carcinogen. NDMA was found to form over time in ranitidine products, with levels increasing with storage [4][5].
What happened to Zantac recalls?
The recalls of Zantac and its generic versions were comprehensive. The U.S. Food and Drug Administration (FDA) requested the market withdrawal of all prescription and over-the-counter ranitidine-containing products in April 2020 after determining that some of these products contained unacceptable levels of NDMA [4]. Similar actions were taken by regulatory agencies in other countries.
Are there alternatives to Ranitidine hydrochloride?
Yes, several alternatives are available for conditions previously treated with ranitidine hydrochloride. These include other H2 blockers and proton pump inhibitors (PPIs).
* H2 Blockers: Famotidine (Pepcid) and cimetidine (Tagamet) are other medications in the same class as ranitidine that reduce stomach acid [6].
* Proton Pump Inhibitors (PPIs): Omeprazole (Prilosec), esomeprazole (Nexium), lansoprazole (Prevacid), pantoprazole (Protonix), and rabeprazole (AcipHex) are more potent acid reducers and are commonly prescribed for conditions like heartburn, GERD, and ulcers [6].
Where can I find information on drug patents?
Information on drug patents, including those related to ranitidine, can be found on specialized databases and resources. DrugPatentWatch.com provides detailed information on drug patents, exclusivity periods, and patent litigation for a wide range of pharmaceuticals [7].